Stockholm, Feb 28, 2026, 08:07 (CET) — The market is now closed.
- Denmark’s OMXC25 dropped roughly 4.7% this week, with Novo Nordisk dragging the index lower after stumbling on results from an obesity-drug trial.
- The OMX Nordic 40 slipped about 2.2% on the week, despite clawing back some ground with a stronger finish on Friday.
- Attention turns to the March 6 U.S. jobs report and central bank calls expected mid-March, as traders eye what could spark the next move in rate forecasts.
The OMXC25, Denmark’s main blue-chip index, dropped roughly 4.7% last week—worse than any other major index in the Nasdaq Nordic group. The drag came largely from Novo Nordisk, which tumbled over 16% on Monday after a setback in its obesity-drug trial.
This is important right now: trading in the Nordic region remains tightly focused. A big swing in just one heavyweight stock can easily overshadow other moves, and as the week wraps up, investors are left weighing if that pressure sticks to Denmark or spills out into wider risk sentiment.
It’s not the best timing. When markets open Monday, traders are already on edge ahead of the U.S. jobs data coming March 6 — a major macro event. On top of that, strategists say equities remain unsettled as investors try to sort out who actually benefits, or doesn’t, from the rapid pace of AI spending. “Trying to find the winners and losers,” BNY’s John Velis said. Reuters
The OMX Nordic 40 index, covering 40 major Nordic stocks, closed out Friday at 2,617.28 — a 0.61% lift for the session. Still, the gauge ended the week roughly 2.2% lower, according to Nasdaq figures.
Sweden stood out, with Stockholm’s OMXS30 finishing Friday at 3,222.75, gaining 0.55% for the session and around 1.3% for the week. In Finland, the OMXH25 settled at 6,147.52, up 0.93% on Friday and about 0.6% on the week.
Stockholm’s surge late in the week owed much to tech and a few outsized single-stock swings. Technology stood out, jumping 2.5% in a single session—by far the top performer among major sectors—while raw materials trailed. Nibe, which makes heat pumps, and Hexagon, a measurement software firm, both posted strong gains. Boliden, the miner, dropped, per a Finwire market update posted by MarketScreener.
Better Collective got a spotlight boost with its annual results and a fresh set of goals for 2026. “Our highest EBITDA ever,” Co-CEO Jesper Søgaard noted, wrapping up 2025 on that high. He pointed to more spending on AI products as they look toward 2026. EBITDA, a key profit metric in the Nordics, was front and center. Nasdaq News
In Sweden, EQT caught attention after insider buying popped up: Jean Eric Salata, set to become chair, picked up 500,000 shares on Feb. 23 for roughly 137.9 million crowns, per Sweden’s insider registry and a MarketScreener report.
Still, Nordic stocks broke lower, diverging from the wider rally in European equities. According to Reuters, the STOXX 600 closed Friday at a new all-time high, notching its eighth consecutive monthly gain, while the Nordic benchmark slid for the week.
Risk signals stayed choppy right into the bell. U.S. stocks closed out February in the red, posting steep monthly losses as traders juggled AI jitters, tariff questions, and geopolitical tensions. “We were reminded there are still some cracks out there,” said Carson Group’s Ryan Detrick. Reuters
The story isn’t set in stone. Should Novo Nordisk regain its footing and investors circle back to Danish healthcare for deals, sentiment could swing fast. Still, a fresh stumble for obesity drugs, or if U.S. tech triggers another bout of risk aversion, Denmark may stay under pressure and any bounce in the broader Nordic index could stall out.
Investors now turn to the calendar for cues. The U.S. employment report lands March 6, the European Central Bank meets on policy March 18–19, and Sweden’s Riksbank reveals its own decision March 19.
